Villere ST Denis J & Co. LLC Sells 6,008 Shares of Colgate-Palmolive (NYSE:CL)

Villere ST Denis J & Co. LLC lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 2.3% during the third quarter, HoldingsChannel reports. The fund owned 259,683 shares of the company’s stock after selling 6,008 shares during the quarter. Colgate-Palmolive comprises about 2.2% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 24th largest holding. Villere ST Denis J & Co. LLC’s holdings in Colgate-Palmolive were worth $26,958,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. SpiderRock Advisors LLC grew its position in Colgate-Palmolive by 1.2% during the 3rd quarter. SpiderRock Advisors LLC now owns 36,749 shares of the company’s stock worth $3,815,000 after acquiring an additional 437 shares during the last quarter. CWA Asset Management Group LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $2,677,000. AEGON ASSET MANAGEMENT UK Plc grew its position in shares of Colgate-Palmolive by 38.9% in the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 1,165,104 shares of the company’s stock valued at $120,913,000 after buying an additional 326,348 shares during the last quarter. Leavell Investment Management Inc. grew its position in shares of Colgate-Palmolive by 0.9% in the 3rd quarter. Leavell Investment Management Inc. now owns 40,584 shares of the company’s stock valued at $4,213,000 after buying an additional 353 shares during the last quarter. Finally, Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $53,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

CL stock opened at $92.59 on Friday. The business has a 50 day moving average of $100.91 and a 200-day moving average of $98.37. Colgate-Palmolive has a 12-month low of $74.67 and a 12-month high of $109.30. The firm has a market cap of $75.65 billion, a PE ratio of 26.53, a P/E/G ratio of 3.34 and a beta of 0.42. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.16%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have commented on CL. UBS Group upped their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Piper Sandler assumed coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Wednesday. Sanford C. Bernstein upped their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.